1. Home
  2. CLNN vs WYY Comparison

CLNN vs WYY Comparison

Compare CLNN & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
    SELLHOLDBUYas of 17 hours ago
  • WYY
    SELLHOLDBUYas of 17 hours ago
  • Stock Information
  • Founded
  • CLNN 2012
  • WYY 1991
  • Country
  • CLNN United States
  • WYY United States
  • Employees
  • CLNN N/A
  • WYY N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • WYY EDP Services
  • Sector
  • CLNN Health Care
  • WYY Technology
  • Exchange
  • CLNN Nasdaq
  • WYY Nasdaq
  • Market Cap
  • CLNN 35.9M
  • WYY 35.6M
  • IPO Year
  • CLNN N/A
  • WYY 1998
  • Fundamental
  • Price
  • CLNN $3.11
  • WYY $3.27
  • Analyst Decision
  • CLNN Strong Buy
  • WYY Strong Buy
  • Analyst Count
  • CLNN 4
  • WYY 1
  • Target Price
  • CLNN $55.25
  • WYY $7.00
  • AVG Volume (30 Days)
  • CLNN 52.8K
  • WYY 13.5K
  • Earning Date
  • CLNN 05-07-2025
  • WYY 05-14-2025
  • Dividend Yield
  • CLNN N/A
  • WYY N/A
  • EPS Growth
  • CLNN N/A
  • WYY N/A
  • EPS
  • CLNN N/A
  • WYY N/A
  • Revenue
  • CLNN $342,000.00
  • WYY $133,124,648.00
  • Revenue This Year
  • CLNN N/A
  • WYY $28.46
  • Revenue Next Year
  • CLNN $17,399.78
  • WYY $12.97
  • P/E Ratio
  • CLNN N/A
  • WYY N/A
  • Revenue Growth
  • CLNN N/A
  • WYY 31.67
  • 52 Week Low
  • CLNN $2.57
  • WYY $1.83
  • 52 Week High
  • CLNN $9.20
  • WYY $6.25
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 34.57
  • WYY 37.69
  • Support Level
  • CLNN $2.57
  • WYY $3.20
  • Resistance Level
  • CLNN $4.66
  • WYY $3.98
  • Average True Range (ATR)
  • CLNN 0.33
  • WYY 0.18
  • MACD
  • CLNN -0.13
  • WYY -0.03
  • Stochastic Oscillator
  • CLNN 25.60
  • WYY 14.46

Stock Price Comparison Chart: CLNN vs WYY

CLNN
WYY
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April01234567891011121314CLNN VS WYY

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use